News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
708,572 Results
Type
Article (41906)
Company Profile (261)
Press Release (666405)
Multimedia
Podcasts (49)
Webinars (12)
Section
Business (206624)
Career Advice (2038)
Deals (35757)
Drug Delivery (95)
Drug Development (81732)
Employer Resources (172)
FDA (16333)
Job Trends (15061)
News (349126)
Policy (33039)
Tag
Academia (2644)
Academic (1)
Accelerated approval (5)
Adcomms (20)
Allergies (86)
Alliances (50392)
ALS (88)
Alzheimer's disease (1394)
Antibody-drug conjugate (ADC) (126)
Approvals (16337)
Artificial intelligence (255)
Autoimmune disease (22)
Automation (16)
Bankruptcy (365)
Best Places to Work (11716)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (182)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (280)
Cancer (2284)
Cardiovascular disease (178)
Career advice (1706)
Career pathing (31)
CAR-T (154)
Cell therapy (433)
Cervical cancer (20)
Clinical research (66380)
Collaboration (844)
Compensation (535)
Complete response letters (20)
COVID-19 (2670)
CRISPR (41)
C-suite (243)
Cystic fibrosis (100)
Data (2214)
Decentralized trials (2)
Denatured (18)
Depression (43)
Diabetes (271)
Diagnostics (6548)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (122)
Drug pricing (98)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (87122)
Editorial (36)
Employer branding (21)
Employer resources (146)
Events (113403)
Executive appointments (727)
FDA (17597)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (761)
Gene editing (106)
Generative AI (19)
Gene therapy (305)
GLP-1 (719)
Government (4473)
Grass and pollen (4)
Guidances (65)
Healthcare (18972)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (119)
Indications (29)
Infectious disease (2815)
Inflammatory bowel disease (137)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (96)
Interviews (315)
IPO (16586)
IRA (40)
Job creations (3755)
Job search strategy (1450)
Kidney cancer (10)
Labor market (38)
Layoffs (472)
Leadership (18)
Legal (8032)
Liver cancer (75)
Lung cancer (326)
Lymphoma (155)
Machine learning (7)
Management (58)
Manufacturing (306)
MASH (68)
Medical device (13448)
Medtech (13453)
Mergers & acquisitions (19713)
Metabolic disorders (687)
Multiple sclerosis (80)
NASH (17)
Neurodegenerative disease (89)
Neuropsychiatric disorders (27)
Neuroscience (1929)
NextGen: Class of 2025 (6562)
Non-profit (4538)
Now hiring (39)
Obesity (364)
Opinion (208)
Ovarian cancer (75)
Pain (87)
Pancreatic cancer (83)
Parkinson's disease (149)
Partnered (21)
Patents (233)
Patient recruitment (111)
Peanut (47)
People (57992)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20719)
Phase II (29221)
Phase III (21759)
Pipeline (1206)
Policy (138)
Postmarket research (2587)
Preclinical (8909)
Press Release (69)
Prostate cancer (108)
Psychedelics (30)
Radiopharmaceuticals (254)
Rare diseases (381)
Real estate (6123)
Recruiting (65)
Regulatory (22621)
Reports (46)
Research institute (2390)
Resumes & cover letters (350)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (69)
Series A (134)
Series B (84)
Service/supplier (11)
Sickle cell disease (54)
Special edition (14)
Spinal muscular atrophy (148)
Sponsored (32)
Startups (3633)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (39)
The Weekly (29)
Vaccines (710)
Venture capitalists (41)
Weight loss (236)
Women's health (35)
Worklife (16)
Date
Today (203)
Last 7 days (897)
Last 30 days (2664)
Last 365 days (33137)
2025 (10762)
2024 (35493)
2023 (40400)
2022 (51546)
2021 (56121)
2020 (54596)
2019 (47013)
2018 (35370)
2017 (32596)
2016 (32062)
2015 (38069)
2014 (31906)
2013 (27012)
2012 (29137)
2011 (29826)
2010 (27866)
Location
Africa (734)
Alabama (53)
Alaska (7)
Arizona (234)
Arkansas (13)
Asia (38746)
Australia (6356)
California (6149)
Canada (2022)
China (525)
Colorado (268)
Connecticut (274)
Delaware (148)
Europe (83724)
Florida (912)
Georgia (207)
Idaho (57)
Illinois (540)
India (25)
Indiana (308)
Iowa (11)
Japan (162)
Kansas (104)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (900)
Massachusetts (4595)
Michigan (220)
Minnesota (394)
Mississippi (2)
Missouri (88)
Montana (30)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1734)
New Mexico (30)
New York (1754)
North Carolina (984)
North Dakota (8)
Northern California (2682)
Ohio (208)
Oklahoma (14)
Oregon (34)
Pennsylvania (1380)
Puerto Rico (12)
Rhode Island (33)
South America (1129)
South Carolina (23)
South Dakota (1)
Southern California (2313)
Tennessee (101)
Texas (914)
United States (23244)
Utah (182)
Virginia (146)
Washington D.C. (61)
Washington State (553)
West Virginia (3)
Wisconsin (55)
708,572 Results for "antigen laboratories inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
The Chimeric Antigen Receptor (CAR) T-Cell Therapy markets to reach US$ 12,482.2 Million by 2035, exhibiting, Impelled by Technological Advancements in CAR-T Therapy
Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Outlook 2025-2035:
February 17, 2025
·
13 min read
Press Releases
Everest Medicines Announces FDA Clearance of IND Application for Tumor-Associated Antigen Vaccine EVM14
March 24, 2025
·
9 min read
Press Releases
Epitopea Announces License and Research Collaboration Agreement with MSD to Identify Cryptigen™ Tumor-Specific Antigens
February 20, 2025
·
3 min read
Cancer
Merck and Epitopea Join Forces to Identify Unknown Tumor Antigens
The agreement, in which Merck will pay the biotech an undisclosed initial sum to license drugs targeting a solid tumor, could net Epitopea up to $300 million down the line.
February 19, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
DAAN Biotherapeutics and GC Cell Sign Exclusive Technology Transfer Agreement for Tumor Antigen-Specific Antibody Sequence to Advance CAR-T and CAR-NK Cell Therapies
April 21, 2025
·
1 min read
IDEXX Expands Fecal Dx® Antigen Testing Platform with Cystoisospora Detection, Marking the Second Platform Expansion in Less than Two Years
IDEXX Laboratories, Inc. announced the expansion of its Fecal Dx ® antigen testing platform with the addition of Cystoisospora.
January 12, 2024
·
6 min read
Press Releases
AUA 2025: New Data from Post-Hoc Analyses Shared on Ultra-Low Prostate-Specific Antigen (PSA) Response in Patients with Metastatic Hormone-Sensitive Prostate Cancer Receiving NUBEQA® (darolutamide) plus Androgen Deprivation Therapy (ADT)
April 30, 2025
·
13 min read
Press Releases
Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).
July 1, 2024
·
5 min read
Press Releases
OraSure Receives Federal Funding for Development of Marburg Virus Rapid Antigen Test
December 3, 2024
·
7 min read
Press Releases
CovarsaDx® Research Team Provides Key Support for the FDA 510(k) Clearance for OSANG Healthcare’s Over-The-Counter QuickFinder™ COVID-19/Flu Antigen Self-Test and QuickFinder™ COVID-19/Flu Antigen Pro Test
January 21, 2025
·
3 min read
1 of 70,858
Next
